Abstract:Objective:To assess the efficacy of two tocolytic agents, ritodrine hydrochloride and atosiban, for inhibiting preterm labour.Methods:The clinical data of 284 patients diagnosed with preterm labour, hospitalised and delivered in Women′s Hospital School of Medicine Zhejiang University from December 2018 to December 2020 were retrospectively reviewed.They were divided into three groups which are the intravenous ritodrine hydrochloride group, the atosiban group, and the alternative group according to the use of tocolysis.Screening for statistically significant outcome indicators by group comparison and controlling the confounding factors by Logistic regression, the maternal and neonatal outcomes were compared among three groups and quantitatively assessmented by corrected OR.Results:（1）Atosiban（OR 7.932,95%CI 1.722-36.526）group and alternative（OR 4.054,95%CI 1.649-9.965）group showed higher risks of giving birth before 28 weeks than ritodrine hydrochloride group（P＜0.01）.（2）Compared to ritodrine hydrochloride group, atosiban（HR 5.942,95%CI 1.736-20.335）group and alternative（HR 3.030,95%CI 1.565-5.865）group had less increase in the mean gestational age at delivery; the adverse drug reactions in atosiban group were less than those in ritodrine hydrochloride group and alternative group（P＜0.01）.（3）No apparent differences were showed between ritodrine hydrochloride and other two groups in live birth rate（P＞0.05）.（4）There were also no significant differences between ritodrine hydrochloride group and atosiban group in infant admission to neonatal intensive care unit（NICU）,neonatal respiratory distress syndrome（NRDS）,apnea, or need for mechanical ventilation.While there were higher event rates for these risks in alternative group compared with ritodrine hydrochloride group（P＜0.05）,OR=2.302（95%CI 1.149-4.612）,5.569（95%CI 2.380-13.033）,6.487（95%CI 2.564-16.409）,6.839（95%CI 2.896-16.152）.Conclusions:Monotherapy with ritodrine hydrochloride was more effective than monotherapy with atosiban and alternative therapy with these two medications for inhibiting preterm labour and prolonging the duration of pregnancy.However, atosiban had less adverse drug reactions compared with ritodrine hydrochloride.Suitable use of medications should be explored by further randomized controlled studies.

Phenanthroline relaxes uterine contractions induced by diverse contractile agents by decreasing cytosolic calcium concentration

Effect of S-Adenosylmethionine on the Contraction of Uterine Smooth Muscle of Mice

Clinical Analysis of Tocolysis with Ritodrine Hydrochloride or Atosibanin Treatment of Threatened Preterm Labour

A hydrogen sulphide-releasing non-steroidal anti-inflammatory, ATB-346, significantly attenuates human myometrial contractions

The relaxation effects of natural polyphenols resveratrol and naringenin on gravid and non-gravid myometrium

Tocolytic effect of the monoterpenic phenol isomer, carvacrol, on the pregnant rat uterus

Augmented KCa2.3 Channel Feedback Regulation of Oxytocin Stimulated Uterine Strips from Nonpregnant Mice

TRPM4 contribution in mouse uterine contractions

Prophylactic Phenylephrine Increases the Dose Requirement of Oxytocin to Treat Uterine Atony During Cesarean Delivery: A Double-Blinded, Single-Center, Randomized and Placebo-Controlled Trial

[Scanning of drug targets related to uterus contraction from the uterine smooth muscles by cDNA microarray]

Isoindolines and phthalides from the rhizomes of Ligusticum chuanxiong and their relaxant effects on the uterine smooth muscle

Paeoniflorin, a novel heat-shock protein inducing compound, and human myometrial contractility in vitro

Mechanism of relaxation via TASK-2 channels in uterine circular muscle of mouse

Effect of Leonurine Hydrochloride on Endothelin and the Endothelin Receptor-Mediated Signal Pathway in Medically-Induced Incomplete Abortion in Rats.

Pimpinella anisum extract attenuates spontaneous and agonist-induced uterine contraction in term-pregnant rats

The Mechanism Involved in the Inhibition of Resveratrol and Genistein on the Contractility of Isolated Rat Uterus Smooth Muscle

Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium

Oxytocin can regulate myometrial smooth muscle excitability by inhibiting the Na+ -activated K+ channel, Slo2.1

Effects of Novel Phosphodiesterase 4 Inhibitors, Ariflo and SB242126A,on Endothelin-L-induced Contractility of Isolated Human Myometrium

Tocolysis for Acute Preterm Labor: Where Have We Been, Where Are We Now, and Where are We Going?

Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways